Arterial Stiffness as a Risk Factor for Subclinical Coronary Artery Calcification in Predialysis Chronic Kidney

Young Youl Hyun1, Hyang Kim1, Kook-Hwan Oh2

  • 1Department of Internal Medicine, Sungkyunkwan University School of Medicine, Kangbuk Samsung Hospital, Seoul, Republic of Korea.

Insights

Increased arterial stiffness, measured by brachial-ankle pulse wave velocity (baPWV), is linked to coronary artery calcification (CAC) in chronic kidney disease (CKD) patients. Further research is needed to confirm this association

Area of Science:

  • Cardiovascular Medicine
  • Nephrology
  • Radiology

Background:

  • Arterial stiffness and coronary artery calcification (CAC) are key cardiovascular disease (CVD) predictors.
  • The association between arterial stiffness and CAC is established in the general population but less understood in chronic kidney disease (CKD) patients.

Purpose of the Study:

  • To investigate the relationship between arterial stiffness and CAC in predialysis CKD patients.
  • To determine if increased arterial stiffness is associated with a higher prevalence and severity of CAC in this population.

Main Methods:

  • Cross-sectional analysis of 1,385 predialysis CKD patients from the KNOW-CKD cohort.
  • Arterial stiffness assessed using brachial-ankle pulse wave velocity (baPWV), with participants grouped by quartile.
  • Coronary artery calcification (CAC) assessed via cardiac computed tomography, with CAC defined as a coronary artery calcium score (CACS) >100.

Main Results:

  • CAC prevalence significantly increased across higher baPWV quartiles (43.8% in the highest vs. 6.4% in the lowest).
  • Fully adjusted analyses showed a 3.03-fold higher CACS ratio and a 1.98-fold increased odds of CAC in the highest baPWV quartile compared to the lowest.
  • Results remained consistent across different CAC definitions and subgroups.

Conclusions:

  • Elevated arterial stiffness, indicated by high baPWV, is significantly associated with CAC in predialysis CKD patients.
  • Longitudinal studies are warranted to elucidate the causal role of arterial stiffness in the development and progression of CAC within the CKD population.
Abstract

Related Concept Videos

Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
934
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
400
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
230
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
351
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
615
Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
612